Atlas Trials

Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders

Clinical trial NCT06423651 · UNKNOWN

Trial details

NCT number
NCT06423651
Sponsor
Universitat Autonoma de Barcelona
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
SchizophreniaSchizophreniform DisordersDelusional DisorderBrief Psychotic DisorderSchizoaffective DisorderSchizophrenia Spectrum and Other Psychotic Disorders
Start date
2022-09-01
Primary completion
2024-12-31
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.